half life semaglutide injection Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes | Clinical Pharmacokinetics A new study is raising

MT1: The typical starting dose for MT1 is around 1mg

Chen X, et al

All right reserved

What dose you run?I started mt2 again this time like 2 weeks ago

The most serious side effects include gastroparesis (stomach paralysis), bowel obstruction or ileus requiring surgery, intestinal blockage, gallbladder disease, vision loss including NAION (non-arteritic anterior ischemic optic neuropathy and arteritic anterior ischemic optic neuropathy), sudden vision loss or blindness, deep vein thrombosis (blood clots), severe malnutrition, and organ damage from prolonged gastrointestinal injuries

But the comparison between starting doses within the same maintenance dose was equally important